The federal Project Grant award of $1,008,313.00 was provided by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The grant, awarded on September 1, 2024, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The award will fund innovative scientific investigations spanning basic, applied,...
The Defense Health Agency awarded a $1,041,595.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The three-year award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. UCSF, a prominent academic medical center and research institution, will conduct innovative...
This $300,000 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The award is intended to support research focused on "Identifying Regulators of Extrafollicular Plasma Cell Differentiation" over the July 2024 to July 2026 performance period. As a leading academic medical center, UCSF will leverage its expertise in biomedical research...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research into the pathobiology of maladaptive clonal hematopoiesis driven by monosomy 7 in GATA2 deficiency. The $850,645 award was granted to The Regents of the University of California, San Francisco, a prominent academic medical center and research institution, for a performance period from Sep 1, 2024 to Aug 31, 2027. The research aims to...
The University of California, San Francisco (UCSF) was awarded a $6,778,819 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will fund a 4-year research project to conduct low-pass whole-genome sequencing to improve breast cancer risk assessment in a diverse population. UCSF will serve as the prime awardee, with the University of Chicago receiving a sub-award to contribute...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
This federal Project Grant award of $997,060 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to develop a new understanding of selective neuron vulnerability and neuroprotection in progressive multiple sclerosis. The award has a performance period from September 15, 2024 to September 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...
This $807,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Regents of the University of California, San Francisco (UCSF) in targeting the PIM kinase pathway to eliminate breast cancer metastasis. The project will be conducted from July 1, 2023 to June 30, 2025. UCSF is a prime grantee with relevant expertise in biomedical research and healthcare services, having previously contracted with federal agencies like...